Article
Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
1 Dec 2003
Abstract excerpt
Myeloperoxidase (MPO) is an haemoprotein that metabolizes tobacco smoke procarcinogens such as benzo(a)pyrene and aromatic amines into highly reactive intermediates. A polymorphism in the MPO promoter (-463G>A), resulting in lower expression, was previously associated with a decrease in lung cancer risk. In this study, the MPO gene was analysed for new polymorphisms by denaturing high-performance liquid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
